Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity
© 2024. The Author(s)..
BACKGROUND: Cytokine storm is known to impact the prognosis of coronavirus disease 2019 (COVID-19), since pro-inflammatory cytokine variants are associated with cytokine storm. It is tempting to speculate that pro-inflammatory cytokines variants may impact COVID-19 outcomes by modulating cytokine storm. Here, we verified this hypothesis via a comprehensive analysis.
METHODS: PubMed, Cochrane Library, Central, CINAHL, and ClinicalTrials.gov were searched until December 15, 2023. Case-control or cohort studies that investigated the impacts of rs1800795 or rs1800629 on COVID-19 susceptibility, severity, mortality, IL-6, TNF-α, or CRP levels were included after an anonymous review by two independent reviewers and consultations of disagreement by a third independent reviewer.
RESULTS: 47 studies (8305 COVID-19 individuals and 17,846 non-COVID-19 individuals) were analyzed. The rs1800629 A allele (adenine at the -308 position of the promoter was encoded by the A allele) was associated with higher levels of tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP). In contrast, the rs1800795 C allele (cytosine at the -174 position of the promoter was encoded by the C allele) was linked to higher levels of interleukin-6 (IL-6) and CRP. In addition, the A allele of rs1800629 increased the severity and mortality of COVID-19. However, the C allele of rs1800795 only increased COVID-19 susceptibility.
CONCLUSIONS: rs1800629 and rs1800795 variants of pro-inflammatory cytokines have significant impacts on systemic inflammatory profile and COVID-19 clinical outcomes. rs1800629 may serve as a genetic marker for severe COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of epidemiology and global health - (2024) vom: 20. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Deng, XueJun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Coronavirus disease 2019 |
---|
Anmerkungen: |
Date Revised 20.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1007/s44197-024-00204-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368668185 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368668185 | ||
003 | DE-627 | ||
005 | 20240220232438.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240220s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s44197-024-00204-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1300.xml |
035 | |a (DE-627)NLM368668185 | ||
035 | |a (NLM)38376765 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Deng, XueJun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Cytokine storm is known to impact the prognosis of coronavirus disease 2019 (COVID-19), since pro-inflammatory cytokine variants are associated with cytokine storm. It is tempting to speculate that pro-inflammatory cytokines variants may impact COVID-19 outcomes by modulating cytokine storm. Here, we verified this hypothesis via a comprehensive analysis | ||
520 | |a METHODS: PubMed, Cochrane Library, Central, CINAHL, and ClinicalTrials.gov were searched until December 15, 2023. Case-control or cohort studies that investigated the impacts of rs1800795 or rs1800629 on COVID-19 susceptibility, severity, mortality, IL-6, TNF-α, or CRP levels were included after an anonymous review by two independent reviewers and consultations of disagreement by a third independent reviewer | ||
520 | |a RESULTS: 47 studies (8305 COVID-19 individuals and 17,846 non-COVID-19 individuals) were analyzed. The rs1800629 A allele (adenine at the -308 position of the promoter was encoded by the A allele) was associated with higher levels of tumor necrosis factor-α (TNF-α) and C-reactive protein (CRP). In contrast, the rs1800795 C allele (cytosine at the -174 position of the promoter was encoded by the C allele) was linked to higher levels of interleukin-6 (IL-6) and CRP. In addition, the A allele of rs1800629 increased the severity and mortality of COVID-19. However, the C allele of rs1800795 only increased COVID-19 susceptibility | ||
520 | |a CONCLUSIONS: rs1800629 and rs1800795 variants of pro-inflammatory cytokines have significant impacts on systemic inflammatory profile and COVID-19 clinical outcomes. rs1800629 may serve as a genetic marker for severe COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Coronavirus disease 2019 | |
650 | 4 | |a Cytokine storm | |
650 | 4 | |a IL-6 | |
650 | 4 | |a Severity | |
700 | 1 | |a Tang, Kai |e verfasserin |4 aut | |
700 | 1 | |a Wang, Zhiqiang |e verfasserin |4 aut | |
700 | 1 | |a He, Suyu |e verfasserin |4 aut | |
700 | 1 | |a Luo, Zhi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of epidemiology and global health |d 2011 |g (2024) vom: 20. Feb. |w (DE-627)NLM226225496 |x 2210-6014 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:20 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s44197-024-00204-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 20 |c 02 |